Company Performance - Southern First (SFST) reported quarterly earnings of $0.65 per share, exceeding the Zacks Consensus Estimate of $0.61 per share, and showing a significant increase from $0.31 per share a year ago, representing an earnings surprise of 6.56% [1] - The company posted revenues of $26.5 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 3.95%, compared to $21.31 million in the same quarter last year [2] - Over the last four quarters, Southern First has consistently surpassed consensus EPS estimates four times and topped consensus revenue estimates three times [2] Stock Outlook - Southern First shares have declined approximately 18.7% since the beginning of the year, while the S&P 500 has decreased by 12.3% [3] - The current consensus EPS estimate for the upcoming quarter is $0.65 on revenues of $26.31 million, and for the current fiscal year, it is $2.67 on revenues of $106.66 million [7] - The estimate revisions trend for Southern First is currently favorable, leading to a Zacks Rank 1 (Strong Buy) for the stock, indicating expected outperformance in the near future [6] Industry Context - The Banks - Southeast industry, to which Southern First belongs, is currently ranked in the top 33% of over 250 Zacks industries, suggesting a positive outlook for stocks within this sector [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]

Core Insights - Valmont Industries reported quarterly earnings of $4.32 per share, exceeding the Zacks Consensus Estimate of $4.24 per share, with an earnings surprise of 1.89% [1] - The company posted revenues of $969.31 million for the quarter, missing the Zacks Consensus Estimate by 0.64%, compared to $977.83 million in the same quarter last year [2] - Valmont has surpassed consensus EPS estimates in all four of the last quarters, while it has topped revenue estimates twice during the same period [2] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $4.72 on revenues of $1.04 billion, and for the current fiscal year, it is $18.01 on revenues of $4.09 billion [7] - The estimate revisions trend for Valmont is mixed, resulting in a Zacks Rank 3 (Hold), indicating expected performance in line with the market [6] Industry Context - The Steel - Pipe and Tube industry, to which Valmont belongs, is currently ranked in the bottom 24% of over 250 Zacks industries, suggesting potential challenges ahead [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which could impact Valmont's stock performance [5]

Group 1 - Verizon Communications reported quarterly earnings of $1.19 per share, exceeding the Zacks Consensus Estimate of $1.15 per share, and showing an increase from $1.15 per share a year ago, representing an earnings surprise of 3.48% [1] - The company posted revenues of $33.49 billion for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 0.48%, and an increase from $32.98 billion year-over-year [2] - Verizon has outperformed the S&P 500, with shares increasing about 7.4% since the beginning of the year, while the S&P 500 has declined by 12.3% [3] Group 2 - The current consensus EPS estimate for the upcoming quarter is $1.20 on revenues of $33.35 billion, and for the current fiscal year, it is $4.70 on revenues of $136.65 billion [7] - The Zacks Industry Rank indicates that the Wireless National industry is in the top 13% of over 250 Zacks industries, suggesting a favorable outlook for stocks within this sector [8]

Company Performance - Halliburton reported quarterly earnings of $0.60 per share, matching the Zacks Consensus Estimate, but down from $0.76 per share a year ago [1] - The company posted revenues of $5.42 billion for the quarter ended March 2025, exceeding the Zacks Consensus Estimate by 3.04%, but down from $5.8 billion year-over-year [2] - Over the last four quarters, Halliburton has not surpassed consensus EPS estimates and has topped consensus revenue estimates only once [2] Stock Movement and Outlook - Halliburton shares have declined approximately 19.4% since the beginning of the year, compared to a 12.3% decline in the S&P 500 [3] - The company's future stock performance will largely depend on management's commentary during the earnings call and the earnings outlook [3][4] - Current consensus EPS estimate for the upcoming quarter is $0.63 on revenues of $5.46 billion, and for the current fiscal year, it is $2.58 on revenues of $22.18 billion [7] Industry Context - The Oil and Gas - Field Services industry, to which Halliburton belongs, is currently ranked in the top 34% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact Halliburton's stock performance [5][6]

Core Insights - Herc Holdings reported quarterly earnings of $1.30 per share, missing the Zacks Consensus Estimate of $2.51 per share, and down from $2.36 per share a year ago, representing an earnings surprise of -48.21% [1] - The company posted revenues of $844 million for the quarter, surpassing the Zacks Consensus Estimate by 0.31%, and up from $804 million year-over-year [2] - The stock has underperformed, losing about 41.1% since the beginning of the year compared to the S&P 500's decline of -12.3% [3] Earnings Performance - Over the last four quarters, Herc Holdings has not surpassed consensus EPS estimates [2] - The current consensus EPS estimate for the upcoming quarter is $2.92 on revenues of $873.26 million, and for the current fiscal year, it is $12.07 on revenues of $3.53 billion [7] Market Outlook - The estimate revisions trend for Herc Holdings is currently unfavorable, resulting in a Zacks Rank 5 (Strong Sell), indicating expected underperformance in the near future [6] - The Transportation - Equipment and Leasing industry is in the bottom 12% of Zacks industries, suggesting that the outlook for the industry can significantly impact stock performance [8]

Company Overview - uniQure (QURE) shares increased by 38.5% in the last trading session, closing at $13, following a notable volume of shares traded, contrasting with a 33.1% loss over the past four weeks [1] - The stock's rally was driven by the FDA granting Breakthrough Therapy designation to its pipeline candidate, AMT-130, for treating Huntington's disease, a rare neurodegenerative disorder [1] Financial Performance - The company is expected to report a quarterly loss of $1.07 per share, reflecting a year-over-year increase of 21.3%, while revenues are projected to be $6 million, down 29.3% from the same quarter last year [2] - The consensus EPS estimate for uniQure has remained unchanged over the last 30 days, indicating that stock price movements may not sustain without trends in earnings estimate revisions [3] Industry Context - uniQure is part of the Zacks Medical - Biomedical and Genetics industry, where Kiniksa Pharmaceuticals, Ltd. (KNSA) experienced a 1.6% decline in the last trading session, with a -11% return over the past month [3] - Kiniksa Pharmaceuticals has a consensus EPS estimate of $0.06 for its upcoming report, representing a 124% increase from the previous year, and currently holds a Zacks Rank of 2 (Buy) [4]

Core Viewpoint - Analysts project that Meritage Homes (MTH) will report quarterly earnings of $1.71 per share, reflecting a year-over-year decline of 32.4%, with revenues expected to reach $1.35 billion, down 8.4% from the same quarter last year [1]. Earnings Estimates - Over the past 30 days, the consensus EPS estimate has been adjusted downward by 0.5%, indicating a reassessment by covering analysts [2]. - Changes in earnings estimates are crucial for predicting investor reactions, as empirical research shows a strong correlation between earnings estimate revisions and short-term stock performance [3]. Revenue Projections - Analysts estimate total closing revenue for homebuilding at $1.35 billion, representing an 8% decline from the prior-year quarter [5]. - Home closing revenue is also projected at $1.35 billion, indicating an 8.1% decrease from the same quarter last year [5]. - Financial services revenue is expected to reach $6.42 million, showing a 1% increase from the year-ago quarter [5]. Home Orders and Backlog - Total homes ordered are projected to be 4,222, up from 3,991 reported in the same quarter last year [6]. - Average sales price for home closing revenue is expected to be $399.89, down from $418 in the previous year [6]. - Order backlog is estimated at 2,398, compared to 3,033 reported in the same quarter last year [6]. Homes Closed and Backlog Value - The consensus estimate for total homes closed is 3,368, down from 3,507 in the previous year [7]. - Order backlog average sales price is projected at $404.29, compared to $410 in the same quarter last year [7]. - Order backlog value is expected to reach $975.98 million, down from $1.24 billion in the previous year [7]. Active Communities and Home Orders Value - Analysts estimate that active communities will total 300, compared to 275 in the previous year [8]. - Homes ordered value is projected to be $1.68 billion, slightly up from $1.63 billion in the previous year [8]. Average Sales Price - Home orders average sales price is expected to be $399.08, down from $409 in the same quarter last year [9]. Stock Performance - Over the past month, Meritage shares have declined by 7.5%, compared to a 5.6% decline in the Zacks S&P 500 composite [10].

Analysts on Wall Street project that The Hartford Insurance Group (HIG) will announce quarterly earnings of $2.13 per share in its forthcoming report, representing a decline of 9% year over year. Revenues are projected to reach $4.84 billion, increasing 11.6% from the same quarter last year.The consensus EPS estimate for the quarter has been revised 0.4% higher over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates ...

Company Overview - Eli Lilly (LLY) shares increased by 14.3% to close at $839.96, following a notable trading volume that exceeded typical levels. This rise contrasts with a 12.2% loss over the previous four weeks [1][2]. Drug Development - The stock's surge was driven by positive topline results from the phase III ACHIEVE-1 study of orforglipron for type 2 diabetes (T2D), which showed a significant reduction in A1C levels by 1.3% to 1.6% over 40 weeks. Over 65% of patients on the highest dose achieved A1C levels of 6.5% or lower, and patients lost an average of 16 pounds (7.9%) [2]. Financial Performance - Eli Lilly is projected to report quarterly earnings of $4.44 per share, reflecting a year-over-year increase of 72.1%. Expected revenues are $12.64 billion, up 44.2% from the same quarter last year [3]. Earnings Estimates - The consensus EPS estimate for Eli Lilly has been revised 1.1% higher in the last 30 days, indicating a positive trend that typically correlates with stock price appreciation [4]. Industry Context - Eli Lilly is part of the Zacks Large Cap Pharmaceuticals industry, where Merck (MRK) also operates. Merck's stock closed 2% higher at $78, but has seen a return of -18.7% over the past month [4].

Company Performance - Netflix reported quarterly earnings of $6.61 per share, exceeding the Zacks Consensus Estimate of $5.69 per share, and up from $5.28 per share a year ago, representing an earnings surprise of 16.17% [1] - The company posted revenues of $10.54 billion for the quarter ended March 2025, slightly missing the Zacks Consensus Estimate by 0.04%, but up from $9.37 billion year-over-year [2] - Over the last four quarters, Netflix has surpassed consensus EPS estimates four times and topped consensus revenue estimates three times [2] Stock Performance - Netflix shares have increased approximately 7.9% since the beginning of the year, contrasting with the S&P 500's decline of -10.3% [3] - The current consensus EPS estimate for the upcoming quarter is $6.22 on revenues of $10.96 billion, and for the current fiscal year, it is $24.50 on revenues of $44.4 billion [7] Industry Outlook - The Broadcast Radio and Television industry, to which Netflix belongs, is currently ranked in the top 34% of over 250 Zacks industries, indicating a favorable outlook [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact Netflix's stock performance [5][6]